secwatch.observer — SEC 8-K summary
======================================

Issuer:     Acorda Therapeutics, Inc. (—)
CIK:        0001008848
Form:       8-K
Filed at:   2024-04-17T23:59:59+00:00
Accession:  0000950170-24-044938
Event type: other_material
Sentiment:  negative
Materiality: 0.90
Item codes: 3.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Acorda Therapeutics delisted from Nasdaq, now trades OTC Pink under ACORQ after Chapter 11
--------------------------------------------------------------------------------

- Common stock ceased trading on Nasdaq on April 12, 2024; now quoted on OTC Pink Open Market under ACORQ.
- Delisting triggered by failure to comply with Nasdaq Listing Rules 5101, 5110(b), and 5450(b)(1)(A) due to Chapter 11 proceedings and stockholders' equity below $10M.
- Nasdaq will file Form 25 to remove securities from registration under Section 12(b) of the Exchange Act; delisting effective 10 days after filing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1008848/000095017024044938/0000950170-24-044938-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1008848/000095017024044938/acor-20240412.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-044938

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer